-
January 29, 2010
The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and...
-
January 29, 2010
WASHINGTON (Reuters) – The number of U.S. Food and Drug Administration warnings to drugmakers and others for questionable drug promotion...
-
January 28, 2010
Theravance, Inc. announced today that it has received from the U.S. Food and Drug Administration (FDA) a letter indicating that...
-
January 26, 2010
The U.S. Food and Drug Administration approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and...
-
January 25, 2010
Larry Risen, President of BioTrak Market Intelligence, a leading provider of REMS assessment design and implementation consulting services, shares how...
-
January 25, 2010
The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some...
-
January 25, 2010
Larry Risen, President of BioTrak Market Intelligence, a leading provider of REMS assessment design and implementation consulting services, shares a...
-
January 25, 2010
Larry Risen, President of BioTrak Market Intelligence, a leading provider of REMS assessment design and implementation consulting services, shares a...
-
January 25, 2010
Larry Risen, President of BioTrak Market Intelligence, a leading provider of REMS assessment design and implementation consulting services, shares a...
-
January 25, 2010
BioTrak assists pharmaceutical companies with designing and implementing Risk Evaluation and Mitigation Strategy (REMS) programs and assessments. BioTrak also develops...
